AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
about
Minority Representation in Migraine Treatment Trials.Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.A novel intranasal breath-powered delivery system for sumatriptan: a review of technology and clinical application of the investigational product AVP-825 in the treatment of migraine.The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.Update on the Pharmacological Treatment of Chronic Migraine.New treatments for headache.Current prospects and future challenges for nasal vaccine delivery.The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine.Sumatriptan Nasal Powder: A Review in Acute Treatment of Migraine.Triptans and migraine: advances in use, administration, formulation, and development.Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.Treatment Update of Chronic Migraine.AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine.
P2860
Q30238764-5603DCFB-0567-45AB-8F25-BD1731ADA843Q35948724-F0174081-0E93-4F1C-B362-22305C042187Q38539637-D408C962-0C28-4DEF-A4AF-7547B5D6A42EQ38563244-B636D161-EC83-48EC-9558-E1D5CCC1C6EFQ38686130-59D4E29A-BD26-4378-9FA2-2FC6E3512658Q38773593-E120352F-5104-43C5-8D86-9A1B4330B0CFQ38784950-8958BC65-F036-4905-B1DE-A15A01EA969EQ38853704-7D93EB99-D9FB-4F27-9EFC-61197C559D28Q38967012-7B85F77C-7314-47A0-AAF3-D5EC5C9EC3F9Q38994955-CFABF213-9908-49D2-BDBF-A45A06458B20Q39155775-9F47439E-81A5-4C2D-B38B-F8AF1D17A699Q39251409-131C61FA-34A8-4E7E-9F77-CBC1A449B8A8Q39366862-8EBD23C1-98FE-43DE-8C4C-53B7E7EF9F48Q47210467-E720278D-3FD2-47B2-99BE-11F68848B046Q47742941-6DC40F23-38B0-4266-8795-ABADCC04BC0FQ47749005-5F741774-7268-4A64-A951-012B664332EBQ47932320-6C86C499-ECBE-4E83-B0D6-A8D0F20FA066Q52643768-818226D6-6BED-45E9-9A64-EB11A0EF3453Q54920214-2764EEEF-6630-4A0D-BD12-5C8EB432408B
P2860
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
AVP-825 breath-powered intrana ...... trial across multiple attacks
@ast
AVP-825 breath-powered intrana ...... trial across multiple attacks
@en
type
label
AVP-825 breath-powered intrana ...... trial across multiple attacks
@ast
AVP-825 breath-powered intrana ...... trial across multiple attacks
@en
prefLabel
AVP-825 breath-powered intrana ...... trial across multiple attacks
@ast
AVP-825 breath-powered intrana ...... trial across multiple attacks
@en
P2093
P2860
P921
P356
P1433
P1476
AVP-825 breath-powered intrana ...... trial across multiple attacks
@en
P2093
Joao Siffert
John Messina
Per G Djupesland
Ramy A Mahmoud
Roger K Cady
P2860
P304
P356
10.1111/HEAD.12583
P407
P577
2015-05-04T00:00:00Z